This study provides strong evidence of the complex interplay between the oral
microbiome, immunological factors, and metabolites in the context of immunobullous
diseases and OLP. The findings highlight the integral role of oral bacteria in disease
progression, the significance of immune dysregulation, and the potential impact of specific
microbial species and metabolic pathways. These insights give the way for further research
and clinical applications, offering the promise of personalized approaches for diagnosis, and
management of OLP, MMP and PV. Future investigations should focus on discovering the
mechanistic details underlying these associations and validating the identified biomarkers in
larger patient cohorts, ultimately contributing to a deeper understanding of the pathogenesis
of these conditions.